StemCyte, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Covina CA United States (1997)
Status: No NME R&D (1997)

Organization Overview

First Clinical Trial
2011
NCT01471613
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

StemCyte, Inc.